Back to Search Results

Ultrasonographic Evaluation of Fatty Pancreas in Serbian Patients with Non Alcoholic Fatty Liver Disease-A Cross Sectional Study.

School of Medicine, University of Belgrade, 11 000 Belgrade, Serbia. tamara.alempijevic@med.bg.ac.rs. Clinic for Gastroenterology and Hepatology, Clinical Center of Serbia, 11 000 Belgrade, Serbia. tamara.alempijevic@med.bg.ac.rs. Clinic for Gastroenterology and Hepatology, Clinical Center of Serbia, 11 000 Belgrade, Serbia. dragasevicsanja@gmail.com. School of Medicine, University of Belgrade, 11 000 Belgrade, Serbia. drmilicastojkovic@gmail.com. Clinic for Gastroenterology and Hepatology, Clinical Center of Serbia, 11 000 Belgrade, Serbia. drmilicastojkovic@gmail.com. Clinic for Gastroenterology and Hepatology, Clinical Center of Serbia, 11 000 Belgrade, Serbia. sanjazgradic@gmail.com. Institute for Medical Informatics and Biostatistics, School of Dentistry, University of Belgrade, 11 000 Belgrade, Serbia. biljana.milicic@sbb.rs. Division of Hospital Medicine, Mayo Clinic Health System, Eau Claire, WI 54703, USA. igordumic84@gmail.com. Mayo Clinic College of Medicine and Sciences, Rochester, MN 55905, USA. igordumic84@gmail.com. Clinic for Abdominal Surgery-First Surgical Clinic, Clinical Center of Serbia, 11 000 Belgrade, Serbia. kstefan1986@gmail.com. Center for Radiology and MRI, Clinical Center of Serbia, 11 000 Belgrade, Serbia. saponjski.d@gmail.com. School of Medicine, University of Belgrade, 11 000 Belgrade, Serbia. drandrija.antic@gmail.com. Clinic for Abdominal Surgery-First Surgical Clinic, Clinical Center of Serbia, 11 000 Belgrade, Serbia. drandrija.antic@gmail.com. School of Medicine, University of Belgrade, 11 000 Belgrade, Serbia. mbecambeca@yahoo.com. Clinic for Abdominal Surgery-First Surgical Clinic, Clinical Center of Serbia, 11 000 Belgrade, Serbia. mbecambeca@yahoo.com. School of Medicine, University of Belgrade, 11 000 Belgrade, Serbia. dragan.drendo23@gmail.com. Clinic for Gastroenterology and Hepatology, Clinical Center of Serbia, 11 000 Belgrade, Serbia. dragan.drendo23@gmail.com.

Medicina (Kaunas, Lithuania). 2019;(10)
Full text from:

Other resources

Abstract

Background and Objectives: The aim of the study was to determine the association between presences of fatty pancreas (FP) with the features of metabolic syndrome (MeS) in patients with non-alcoholic fatty liver disease (NAFLD) and to establish a new noninvasive scoring system for the prediction of FP in patients with NAFLD. Material and Methods: 143 patients with NAFLD were classified according to FP severity grade into the two groups and evaluated for diagnostic criteria of MeS. All patients underwent sonographic examination with adiposity measurements and the liver biopsy. Liver fibrosis was evaluated semi-quantitatively according to the METAVIR scoring system and using non-invasive markers of hepatic fibrosis. Results: Waist circumference (WC) was predictive for increased risk of FP in NAFLD patients. Elevated fasting plasma glucose, total cholesterol, serum amylase and lipase levels were associated with presence of severe FP (p value = 0.052, p value = 0.007, p value = 0.014; p value = 0.024, respectively). Presence of increased amounts of mesenteric fat was associated with severe FP (p value = 0.013). The results of this study demonstrated highly significant association between NAFLD and presence of FP. The model for predicting the presence of FP was designed with probability value above 6.5. Conclusion: Pancreatic fat accumulation leads to worsening of pancreatic function which in turns exacerbates severity of metabolic syndrome associated with both, NAFLD and NAFPD.

Methodological quality

Publication Type : Observational Study

Metadata

MeSH terms : Ultrasonography